Impact of non-regional lymph node metastases accurately revealed on 18F-PSMA-1007 PET/CT in the clinical management of metastatic hormone-sensitive prostate cancer

EJNMMI Research

Table 2 The concordance rate between ¹⁸F-PSMA-1007 PET/CT and CI

	CI	¹⁸F-PSMA-1007 PET/CT			Concordance rate (%)	Cohen's kappa coefficient
Tumor volume		Low	High		90.91	0.816
	Low	38	9
	High	0	52
T stage		miT2	miT3	miT4	89.90	0.844
	cT2	19	6	1
	cT3	0	30	3
	cT4	0	0	40
N stage		miN0	miN1	miN2	84.85	0.600
	cN0	17	9	4
	cN1	2	28	39
NRLN metastases		Absence	Presence		61.62	0.092
	Absence	57	37
	Presence	1	4
Bone metastases		Absence	Presence		82.83	0.456
	Absence	10	16
	Presence	1	70
Visceral metastases		Absence	Presence		86.87	0.207
	Absence	84	13
	Presence	0	2

CI conventional imaging, PSMA prostate specific membrane antigen, NRLN non-regional lymph node